XtalPi lands massive $319M SoftBank-led round C to continue its high-tech drug discovery
XtalPi, an American-Chinese biotech firm that focuses on AI-assisted drug discovery, has raised a $ 319 million round C from a slate of enthusiastic investors led by SoftBank’s Vision Fund. It joins numerous others with 9-figure rounds in what is clearly a valuable and competitive...
Continue reading »